论文部分内容阅读
循证医学(Evidence-based medicine,EBM)起源于19世纪中期法国大革命之后的巴黎,直到20世纪70年代,许多流行病学家又疾呼临床实践需要证据。20世纪80年代,大规模临床随机对照研究(Randomized Controlled Trials,RCT)蓬勃开展。1980年,EBM开始得到广泛关注。1993年成立了世界循证医学协作网。早在1986年,我国国家攻关课题——老年收缩期高血压临床试验(Syst-China)和上海硝苯地平老年高血压试验(stone)就开创了我国的循证医学研究。以客观事实为依据,以实际疗效为准则的循证医学已成为医学发展和药物治疗史上
Evidence-based medicine (EBM) originated in Paris after the French Revolution in the mid-19th century. Until the 1970s, many epidemiologists were crying out for evidence of clinical practice. In the 1980s, large-scale Randomized Controlled Trials (RCTs) flourished. In 1980, EBM began to receive widespread attention. Established in 1993, the world’s evidence-based medicine network. As early as 1986, China’s national research project - Syst-China Symptomatic Hypertension Trial and Shanghai Nifedipine Hypertension Test-Stone pioneered the development of evidence-based medicine in China. Evidence-based medicine based on objective facts and based on actual efficacy has become a landmark in the history of medical development and drug treatment